Loading...
Loading...
Off-label use of low-dose naltrexone (1.
79/100
Bernard Bihari
Ongoing, improvements typically in 2-3 months
10 phases
6 targeted
Off-label use of low-dose naltrexone (1.5-4.5mg) to modulate immune system and increase endorphins. Originally an opioid antagonist at high dose (50mg), low dose has paradoxical immune-boosting effects.
Strong safety profile, inexpensive ($30-50/month), growing evidence base. Works by blocking opioid receptors temporarily, causing rebound endorphin increase and immune modulation. Many physicians now prescribe. Need compounding pharmacy. Off-label but increasingly accepted.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.